Eisai First Japan Member To Global TB-Research Partnership
This article was originally published in PharmAsia News
Eisai said it has joined the international partnership to help discover new drugs for treating tuberculosis, still a global threat, joining major drug makers such as AstraZeneca, Eli Lilly and Sanofi.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.